Abstract
Whereas Jagged1-Notch2 signaling is known to pattern the sensorineural components of the inner ear, its role in middle ear development has been less clear. We previously reported a role for Jagged-Notch signaling in shaping skeletal elements derived from the first two pharyngeal arches of zebrafish. Here we show a conserved requirement for Jagged1-Notch2 signaling in patterning the stapes and incus middle ear bones derived from the equivalent pharyngeal arches of mammals. Mice lacking Jagged1 or Notch2 in neural crest-derived cells (NCCs) of the pharyngeal arches display a malformed stapes. Heterozygous Jagged1 knockout mice, a model for Alagille Syndrome (AGS), also display stapes and incus defects. We find that Jagged1-Notch2 signaling functions early to pattern the stapes cartilage template, with stapes malformations correlating with hearing loss across all frequencies. We observe similar stapes defects and hearing loss in one patient with heterozygous JAGGED1 loss, and a diversity of conductive and sensorineural hearing loss in nearly half of AGS patients, many of which carry JAGGED1 mutations. Our findings reveal deep conservation of Jagged1-Notch2 signaling in patterning the pharyngeal arches from fish to mouse to man, despite the very different functions of their skeletal derivatives in jaw support and sound transduction.
Similar content being viewed by others
Introduction
Despite their critical importance in sound transduction, we still know relatively little about the developmental patterning of the diminutive ossicles of the mammalian middle ear. The malleus and incus bones are derived from NCCs that populate the first (i.e. mandibular) pharyngeal arch, and the stapes bone is derived from the second (i.e. hyoid) arch1. In a fascinating evolutionary transition, these tiny middle ear bones are thought to have arisen by modification of the ancestral fish jaw-support skeleton, with the malleus, incus, and stapes being homologous to portions of the Meckel’s, palatoquadrate, and hyomandibular elements of fish, respectively2 (Fig. 1a). In a genetic screen in zebrafish, we previously identified a loss-of-function mutation in the JAG1 homolog, jag1b, which resulted in specific malformations of the palatoquadrate and hyomandibular cartilages3. Subsequently, we found that Jag1b works through the Notch2 and Notch3 receptors to regulate bone and cartilage differentiation in the dorsal portions of the mandibular and hyoid arches, regions from which the incus and stapes bones arise in mammals4. We therefore asked in this study whether loss of Jagged-Notch signaling might similarly disrupt development of the stapes and incus bones.
In humans, heterozygous loss-of-function mutations in JAGGED1 (JAG1) have been found in 94% of AGS patients5,6,7, with a small proportion of AGS patients harboring heterozygous loss-of-function mutations in NOTCH2 8, which encodes a receptor for JAG1. Clinical diagnosis of AGS is based on reduced numbers of intrahepatic bile ducts in the liver, accompanied by cholestasis, a characteristic facial appearance, and defects in the heart, eyes, and skeleton9. Although not part of the clinical diagnosis for AGS, there are some reports of hearing loss in patients with AGS and/or mutations in JAG1. Work in mouse and chick has uncovered roles for Jagged-Notch signaling in the patterning of the prosensory domain, which gives rise to the hair and support cells of the cochlea10,11,12. These findings would appear to suggest that hearing loss in AGS is primarily due to sensorineural defects. However, there are also a few isolated reports of conductive hearing loss in AGS, which indicates potential structural defects of the middle ear. In one large AGS kindred, mild conductive hearing loss was noted13. Another kindred, with missense mutations in JAG1 yet only the cardiac defects typically associated with AGS, displayed mixed hearing loss (i.e. combined conductive and sensorineural components)14. In a separate post-mortem analysis of the temporal bone, two AGS individuals were described as having a “bulky” stapes, with one also displaying a “bulky” incus, yet the precise morphological changes of these middle ear bones were unclear15. These studies raise the possibility that defects in not only the neural components of the inner ear but also the structural components of the middle ear might contribute to hearing loss in AGS patients.
Results
Loss of Jag1 or Notch2 in NCCs results in craniofacial and middle ear defects
Homozygous deletion of Jag1 or Notch2 results in early embryonic lethality in mice16, 17. We had previously reported that conditional deletion of Jag1 in NCCs (using Wnt1-Cre) resulted in a persistent foramen in the frontal bone18, and an independent group reported midfacial hypoplasia in these Wnt1-Cre; Jag1 f/f conditional knockout (Jag1-CKO) mice, reminiscent of the facial characteristics of AGS19, 20. Micro-computed tomography (uCT) scans confirmed these previously reported phenotypes in Jag1-CKO mice, and revealed a similar persistent foramen and midfacial hypoplasia in Wnt1-Cre; Notch2 f/f (Notch2-CKO) mice (Fig. 1b). We therefore analyzed the effects of removing both copies of Jag1 or Notch2 in NCCs on middle ear bone development. At postnatal day 21 (P21), Alizarin Red staining of bone in Jag1 f/f controls shows that the stapes consists of two cruces with a prominent foramen. In 100% of Jag1-CKO (n = 8/8) and Notch2-CKO (n = 8/8) mice, the stapes was narrower than in controls and had a reduced or absent foramen (Fig. 1c and Table 1). Whereas the stapes of Jag1-CKO mice were consistently reduced in size, there was some variability in the amount of ectopic mineralization in the reduced foramen (Fig. S1). This single crus phenotype of the stapes has previously been referred to as “columellar” or “monopode”21,22,23,24. In contrast, the malleus and incus bones of Jag1-CKO and Notch2-CKO mice were less affected, with just 12.5% (n = 1/8) of Notch2-CKO mice and no Jag1-CKO mice having an ectopic process extending from the anterior medial edge of the incus body.
As heterozygous loss-of-function mutations in human JAG1 result in AGS, we also examined the effects of removing just one copy of Jag1 throughout the whole mouse (Fig. 1d and Table 1). In Jag1 heterozygotes, we observed a similar columellar stapes in 25% of animals (n = 5/20), and an ectopic process extending from the posterior medial edge of the incus body in 75% of animals (n = 15/20). As with Jag1-CKO mice, the malleus was unaffected in Jag1 heterozygotes. These findings indicate that development of the stapes and incus is especially sensitive to reduced dosage of Jag1-Notch2 signaling in mice.
Jag1 is necessary for early patterning of the stapes cartilage but not formation of the stapedial artery
The lack of a foramen in the mutant stapes could be due to earlier mispatterning of the cartilage template, ectopic mineralization, or loss of the stapedial artery that runs through the normal foramen. We therefore examined the middle ear cartilages of newborn mice, before they are ossified, using Alizarin Red and Alcian Blue to stain for bone and cartilage (Fig. 2a,b and Table 1). In wild-type, Jag1 f/f, and Wnt1-Cre; Jag1 f/+ controls, the stapes cartilage had a prominent foramen. In contrast, Jag1 +/− and Wnt1-Cre; Jag1 f/f mice had a smaller stapes cartilage with a reduced or absent foramen, consistent with the later columellar phenotype of the ossified stapes bone. We next examined the stapedial artery, which normally passes through the stapes and serves as a bridge connecting the external and internal carotid arteries. To visualize this artery in conjunction with the stapes cartilage, we bred the conditional Jag1 mutants onto a Rosa26-Tomato reporter background and injected India ink into the artery after dissecting out the intact middle and inner ear from newborn mice. As in controls, we still observed a prominent stapedial artery in Jag1-CKO mice (n = 3/3), which curved around the misshapen stapes cartilage (Fig. 2c). These findings indicate that the stapes defects in Jag1-deficient mice are likely due to an early mispatterning of the cartilage template rather than loss of the stapedial artery or ectopic mineralization.
Jag1 and Twist1 interact to pattern the incus and retrotympanic process
Because we had previously uncovered a genetic interaction between Jag1 and Twist1 in coronal suture development18, we next examined whether the variable penetrance of middle ear defects in Jag1 heterozygotes might be due in part to genetic interactions with Twist1. In humans, heterozygous loss of TWIST1 results in Saethre-Chotzen syndrome25, a variable feature of which is conductive or mixed hearing loss26, 27. In Twist1 +/− mice, we observed that the stapes and malleus bones were normal, with loss of one Twist1 allele failing to enhance the stapes defects of Jag1 +/− mice (Table 1). In contrast, 38% (n = 6/16) of Twist1 +/− mice developed a prominent ectopic process from the anterior medial edge of the incus body, and in Jag1 +/−; Twist1 +/− mice the penetrance of this phenotype increased to 69% (n = 9/13) (Table 1 and Fig. 3a). The retrotympanic process, a posterior extension of the squamosal bone that lies just above the incus, was also reduced in size and fragmented in Twist1 +/− but not Jag1 +/− single mutants. The penetrance of this phenotype increased from 11% (n = 2/18) to 68% (n = 13/22) in compound heterozygotes (Table 1 and Fig. 3b). These findings reveal a selective interaction between Jag1 and Twist1 in patterning the mandibular arch from which the incus and retrotympanic process derive, and not the hyoid arch from which the stapes derives. As both Twist1 and Jagged-Notch signaling inhibit skeletal differentiation in the head18, 28,29,30, inappropriate skeletal differentiation might underlie both the suture and middle ear bone phenotypes in animals deficient in these factors. Further analysis will be required to determine whether Twist1 and Jagged-Notch signaling function in a linear pathway or in parallel for mandibular arch patterning.
Jag1 is required in NCCs for normal hearing in mice
The stapes and incus bones are essential for normal hearing31, 32. To test whether the ossicular defects of Jag1-CKO mice result in hearing loss, we measured auditory brainstem response (ABR) at P18. In a click stimulus test, in which a large range of frequencies is presented simultaneously, we observed an approximately 30 decibel shift in the sound pressure level (dB SPL) in Jag1-CKO mice compared to Wnt1-Cre; Jag1 f/+ or Jag1 f/+ controls (Fig. 4a). Hearing level thresholds were then measured at the specific frequencies of 4, 8, 12, 16, 24, and 32 kilohertz (kHz). We found a roughly 22 db SPL threshold shift in Jag1-CKO mice across all frequencies, significantly higher than Wnt1-Cre; Jag1 f/+, Jag1 f/+, and Jag1 f/f mice (Fig. 4b). We also found a small but statistically significant high-frequency threshold shift in mice lacking just one copy of Jag1 in NCCs, compared to Jag1 f/+ controls; however this shift appeared to be largely attributable to one animal and was no longer apparent when mice were retested at five weeks of age (Fig. S2). As we deleted Jag1 solely in NCCs, these results are consistent with hearing loss being due to structural defects of the stapes and/or other components of the middle ear. It remains unclear whether the variability in hearing acuity of individual Jag1-CKO animals could be explained by the small differences in stapes morphology observed (Fig. S1). As neural crest-derived cells also make a small contribution to the inner ear, defects in these structures might also contribute to the degree of hearing loss. However, the semicircular canals of the inner ear, which are dysmorphic in Alagille Syndrome14 and conventional Jag1 heterozygous mice11, 33, 34, were unaffected in Jag1-CKO mice (Fig. S3), arguing against canal defects being the cause of hearing loss.
Conductive hearing loss and anomalies in middle ear bones in patients heterozygous for JAG1 loss-of-function mutations
Given the stapes defects in heterozygous Jag1 mutant mice, we investigated whether heterozygous loss of JAG1 might also affect middle ear development and hearing in humans. Conductive and mixed hearing loss have been described in a few kindreds with mutations or deletions in JAG1 13,14,15, yet the prevalence of such hearing loss in AGS was unclear35. We therefore attended the Alagille Alliance meetings in 2011 and 2014 and conducted hearing tests on participants with AGS clinical diagnosis and/or known heterozygous mutations in JAG1. Of the 44 subjects tested, 16 have known mutations in JAG1 and the remaining 28 have not yet been determined (Table S1). The most common finding was conductive hearing loss (27% of left ears, 30% of right ears), followed by mixed hearing loss (14% of left ears, 9% of right ears) and then sensorineural hearing loss (4% of left ears, 11% of right ears) (Fig. 5a and Table S1). We found conductive hearing loss to be primarily mild or moderate, compared to sensorineural and mixed hearing loss, which could be in the severe to profound range (Fig. 5a).
For five participants – one with conductive, two with mixed, one with sensorineural, and one with no hearing loss – and a non-AGS control, we obtained computed tomography (CT) scans of the temporal bone to visualize middle ear structures (summarized in Table 2). CT scans have been shown to be fairly accurate in diagnosing stapes defects36. All five subjects showed abnormalities in the posterior semicircular canals. Three showed defects in the superior semicircular canals, consistent with previous reports of hypoplasia or absence of semicircular canals in AGS14, 37. In a 49-year-old male with severe mixed hearing loss in the left ear and high-frequency hearing loss in the right ear, we observed bilateral malformations of the stapes such that it appeared columellar (i.e. lacking distinct anterior and posterior cruces) (Fig. 5b,c), nearly identical to what we observed in Jag1-deficient mice. This subject has a mutation in exon 19 (c.2345–2A > G) of JAG1 that alters the splicing consensus sequence and leads to heterozygous JAG1 loss-of-function. He also had normal compliance of the tympanic membrane in both ears. These findings are consistent with partial defects in the ossicular chain resulting in high-frequency hearing loss38. We also observed an ectopic process extending from the left incus towards the posterior wall of the tympanic cavity in a 9-year-old subject with sensorineural hearing loss in the right ear, and irregular orientation of the petrous part of the temporal bone, which was sloping upwards in a lateral to medial manner, in an 8-year-old subject with mixed hearing loss in both ears (Table 2). In a 7-year-old subject with mild low-frequency conductive hearing loss in the left ear, middle ear bones were normal yet the aperture of the cochlear nerve was reduced. A 16-year-old subject with normal hearing, who had no defects in the middle ear bones, also displayed abnormal calcification of the left oval window (Fig. 5d). This lesion is suggestive of otosclerosis, in which calcified bone fixes the stapes to the oval window and in some cases limits the ability to transmit sound. In summary, while conductive hearing loss was associated with stapes defects in one subject, our findings show a diversity of structural defects of the middle ear in AGS patients that are variably associated with hearing loss.
Discussion
Our findings indicate a conserved role for Jag1-Notch2 signaling in NCCs for the patterning of the stapes and incus bones of the mammalian middle ear. The fully penetrant stapes defects seen upon NCC-specific deletion of Jag1 or Notch2 are consistent with findings in zebrafish that Jag1b functions in NCCs to pattern the homologous hyomandibular cartilage3. Whereas hyomandibular defects in zebrafish lacking jag1b, or notch2 and notch3, correlate with ectopic expression of the cartilage condensation marker barx1 in the hyoid arch4, we observed no differences in Barx1 expression in the hyoid arches of Jag1-CKO mice at E10.5 and E11.5 (Fig. S4). However, it remains possible that subtle differences in Barx1 expression escaped our detection, especially given the small number of arch NCCs that contribute to the diminutive stapes bone. On the other hand, it seems less likely that stapes defects are a secondary consequence of stapedial artery defects. Jag1 has been shown to be required in endothelial cells, which are not of neural crest origin, for vascular development39. Further, we show that NCC-specific loss of the Notch2 receptor, which is expected to act cell-autonomously in endothelial cells and not NCCs for artery development, causes a similar stapes defect to NCC-specific Jag1 loss. Whereas the stapedial artery is later associated with pericytes, which are of neural crest origin, pericytes are recruited only after artery formation and thus are unlikely to affect the initial routing of the stapedial artery40. Further, the foramen of the stapes homolog (hyomandibula) in zebrafish jag1b mutants is similarly lost, despite this foramen being associated with the facial nerve instead of an artery3. Thus, rerouting of the stapedial artery appears to be a secondary consequence of the reduced stapes anlagen and not vice versa. Nonetheless, additional studies are clearly needed to elucidate the developmental basis of stapes defects in Jag1-deficient mice.
Wnt1-Cre; RBP-J f/f mice with global loss of Notch signaling in NCCs display similar defects in the frontal bone as we observe upon NCC-specific deletion of Jag1 or Notch2 41. Although middle ear bones were not examined in Wnt1-Cre; RBP-J f/f mice, the similarity of stapes defects in Jag1-CKO and Notch2-CKO mice suggest that JAG1 and NOTCH2 are the likely major ligand and receptor for both calvarial and middle ear bone development. Of note, global but not NCC-specific heterozygous loss of Jag1 results in partially penetrant stapes defects, as well as incus defects, suggesting additional requirements for Jag1 in non-NCC tissues for ossicle patterning. One candidate tissue is the first endodermal pouch, which displays strong Jag1 expression in both mice42 and zebrafish3 and develops in close association with the stapes and incus anlagen. Jag2 and Notch3 may also partially compensate for Jag1 and Notch2 in other aspects of NCC skeletal differentiation. Jag2 is required for development of the NCC-derived palate in mice43, and notch3 reduction enhances craniofacial defects in notch2 mutant zebrafish4. However, deletion of Notch1 in neural-crest-derived cells does not cause midfacial hypoplasia characteristic of Alagille Syndrome20, and a previous study did not detect expression of either Notch1 ortholog in the developing zebrafish face3. Interestingly, the liver and heart defects of AGS have not been observed in the analogous Jag1 heterozygous mice17, 44, yet we did observe similar stapes defects in both mice and humans lacking one copy of JAG1. These results indicate that organs have independent dosage sensitivities to JAG1 across species.
While we found a correlation between stapes defects and hearing loss in one individual heterozygous for a JAG1 mutation, the presence of conductive or mixed hearing loss but apparently normal middle ear bones in other AGS patients suggests that middle ear bone defects alone cannot account for conductive hearing loss in this syndrome. NCC-specific Jag1 mutant mice have midfacial hypoplasia, and the development and function of the Eustachian tube is closely associated with the craniofacial skeleton45, 46. Thus, other factors such as Eustachian tube dysfunction may contribute to hearing loss in subjects with apparently normal ossicles. Similarly in NCC-specific Jag1 mutant mice, we cannot rule out the possibility that defects in other NCC-derived ear structures besides the stapes contribute to hearing loss, especially as the ABR test we performed does not distinguish between conductive and sensorineural components. For example, NCC derivatives contribute to the early cochleovestibular ganglion and utricle, as well as a few rare cells in the semicircular canals and stria vascularis47. While the cochleovestibular ganglion and stria vascularis are involved in auditory functions, the utricle and semicircular canals are responsible for balance. Indeed, studies on three mouse mutants – Slalom 33, Headturner 48, and Ozzy 34 – have described specific point mutations in Jag1 resulting in malformations of the semicircular canals, and we and others observe frequent losses and anomalies of the superior and posterior semicircular canals in AGS patients14, 15, 37. Further, the role of Jagged-Notch signaling in the development of the vestibular system also appears to be conserved in zebrafish, as jag1b mutants were independently isolated based on semicircular canal defects49, 50. However, we found that NCC-specific loss of Jag1 in mice causes hearing loss without affecting canal morphology, consistent with defects in the stapes and/or other middle and inner ear structures being responsible for hearing defects in these mice. Nonetheless, superior semicircular canal dehiscence can lead to autophony and conductive hearing loss, and dehiscence of the canal can cause disruption of the normal endolymph flow, resulting in a lower bone conduction and higher air conduction threshold51. Although there are currently no reports linking Jag1 and AGS to canal dehiscence, we cannot rule out a possible canal dehiscence component in AGS-associated hearing loss. In addition, Jag1 has a well-known requirement in patterning the ectodermal sensory placode from which the hair and support cells of the inner ear derive10,11,12, consistent with the finding of sensorineural hearing loss in several AGS patients. These observations indicate a complex etiology of hearing loss in AGS, likely affecting multiple structures in both the middle and inner ear, particularly for those patients presenting with mixed hearing loss. However, for those patients with isolated middle ear bone defects, surgical correction might be an option to improve hearing52.
To date, mutations in only a few genes, such as NOGGIN 53 and ANK 54, have been linked to congenital conductive hearing loss in humans. A contribution of JAG1 mutations to congenital conductive hearing loss thus expands our knowledge of human middle ear development. However, as AGS is relatively rare, we were only able to examine the middle ears of a small number of patients. Thus, the extent to which stapes and/or incus defects occur in this syndrome and contribute to hearing loss remains to be determined. While the similarity in stapes defects between Jag1 mutant mice and an individual with heterozygous loss of JAG1 strongly supports the view that human stapes malformations are due to JAG1 deficiency, we cannot rule out that second site mutations act synergistically with JAG1 mutations to cause middle ear bone defects. For example, conditional deletion studies in mice have revealed requirements for Tbx1 in middle and inner ear structures55, and DiGeorge Syndrome, which is associated with heterozygous deletion of TBX1, encompasses an array of defects that overlap with Alagille Syndrome, including tetralogy of fallot and hearing loss. On the other hand, the patient with stapes defects did not display the multi-organ defects typically associated with AGS, despite having a child with the same JAG1 mutation and typical AGS features. Together with a previous study showing mixed hearing loss in a kindred with a JAG1 missense mutation but only a subset of AGS features14, and the presence of JAG1 mutations presenting with only one or two AGS features56, our results suggest that reduced JAG1 function can cause hearing loss largely independently of other AGS features. It will therefore be informative to examine the extent to which family members of AGS patients who exhibit hearing loss despite the lack of an AGS diagnosis, as well as unrelated patients with defects in the stapes and/or incus bones, carry JAG1 or NOTCH2 mutations.
Materials and Methods
Mouse mutants and genotyping
Animal experiments were approved by the University of Southern California IACUC committee, and all methods were performed in accordance with the relevant guidelines and regulations. Genotyping was performed as previously published for Jag1 17, Twist1 57, Jag1-flox58, Notch2-flox59, Wnt1-Cre 60, and Rosa26-Tomato61 mouse lines.
Micro-computed tomography of mice
Imaging was performed using a MicroCT 50 (Scanco Medical AG, Switzerland), scanning at high resolution [2040 × 2040 in-plane image matrix; 0.18 degree rotational step (DRS)] and a field of view of 20.4 mm. Scans were conducted at an energy setting of 70 kVp, current intensity of 200 µA, and an integration time of 500 ms/projection. Two-dimensional slices taken at 10-micron increments were rendered into three-dimensional reconstructions using Exposure Render62.
Skull preparation
The heads of three-week-old mice were skinned and cleared with 1% KOH for 1 to 2 days, stained with 2% Alizarin Red S in 1% KOH until mineralized bone is red, and stored in 100% glycerol. Middle ear ossicles were then dissected out for analysis. The heads of P0 newborn mice were skinned and double stained with Alcian Blue and Alizarin Red S for cartilage and bone as described63 with minor modifications. Washes in tap water pre and post bone staining were omitted; Alizarin Red S at 0.1% was used at 1:50 dilution in potassium hydroxide (KOH); decolorizing treatment after bone staining was performed with 1% KOH overnight; and the dehydration process was completed through sequentially increasing proportions of 100% glycerol:1% KOH (1:3, 1:1, 3:1, 1:0). Samples were imaged using a Leica S8 APO stereo microscope.
Stapes and stapedial artery visualization
Wnt1-Cre; Jag1 f/+; Rosa26-Tomatoki/+ and Jag1 f/f; Rosa26-Tomatoki/ki mice were bred to generate Wnt1-Cre; Jag1 f/f; Rosa26-Tomato mutants. The heads of P0 newborn mice were skinned, fixed overnight in 4% paraformaldehyde, and stored in phosphate buffered saline (PBS). Whole ear structures were carefully dissected out, and the stapedial artery was injected with India ink using glass capillary needles. The malleus, incus, and other tissues were removed after injections and before imaging to better reveal the stapes. Image z-stacks were taken using a Zeiss Axiozoom and processed using extended depth of field by Zeiss LSM software.
Hearing tests in mice
ABR was performed through inserted earphones, using closed-field acoustics. The sound pressure level (SPL) of the stimuli ranged between 20 and 105 decibels (dB). In determining ABR thresholds, 300 responses with artifacts less than 30 microvolts were averaged. Presentation of stimuli and averaging of responses were both controlled by BioSig software. When ABR threshold was above maximum output range, it was classified as 105 dB. Hearing level thresholds were measured at specific frequencies of 4, 8, 12, 16, 24, and 32 kilohertz (kHz).
Hearing tests and computed tomography (CT) scans on human subjects
Studies on human patients were approved by the Institutional Review Board at the University of Southern California Keck School of Medicine, and all methods were performed in accordance with the relevant guidelines and regulations. Written informed consent to obtain samples for genetics research was obtained from each subject and/or subject’s parent or guardian. Hearing tests were performed at the Alagille Alliance meetings of 2011 and 2014. Otoscopy was performed to check for occluding wax, fluid, or infection, as well as wellness of the canal and middle ear system. The testing used was tympanometry and behavioral audiometry. For tympanometry, a small probe tip is inserted into the ear canal to create a seal, and then air pressure is directed into the external auditory ear canal. The mobility of the eardrum is recorded to confirm the health of the middle ear system. For behavioral audiometry, thresholds of hearing are tested from 250 to 8000 Hz. Test procedures are based on the age of the test subject. If a subject is able to test conventionally by raising their hand only when a test frequency is heard, the standard 10 dB up and 5 dB down testing procedure is performed. Frequencies are tested in conventional order − 1000, 2000, 4000, 8000, 250, 500 Hz. If the difference between octaves is greater or equal to 20 dB, then inner octave threshold is measured. In cases where a subject is too young, unreliable or distracted to complete this testing procedure, conditioned play audiometry is completed. In this form of testing, the subject is trained to perform an action in response to sound, such as dropping a block in a bucket. Frequencies are not presented in any standard order to keep the subject interested. If the patient becomes unreliable, then thresholds are not recorded. In standard air and bone conduction tests, a hearing level of -10 to 25 dBHL (decibels hearing level) is classified as normal, 25 to 40 dBHL as mild, 40 to 70 dBHL as moderate, 70 to 90 dBHL as severe, and 90 dBHL and above as profound. Conductive hearing loss is indicated by decreased air but normal bone conduction, sensorineural hearing loss by decreased air and bone conduction thresholds, and mixed hearing loss by decreased air and bone conduction thresholds with the bone conduction threshold being 10 dB higher than for air. Temporal bone CT scans on subjects 1 and 5 were acquired at the University of Southern California Keck School of Medicine using standard clinical procedures. Temporal bone CT scans for subjects 2, 3, and 4 were kindly provided by the patients’ physicians.
Data Availability
All data generated or analyzed during this study are either included in this published article or available from the corresponding author on request.
References
O’Gorman, S. Second branchial arch lineages of the middle ear of wild-type and Hoxa2 mutant mice. Dev Dyn 234, 124–131, doi:10.1002/dvdy.20402 (2005).
Medeiros, D. M. & Crump, J. G. New perspectives on pharyngeal dorsoventral patterning in development and evolution of the vertebrate jaw. Developmental biology 371, 121–135, doi:10.1016/j.ydbio.2012.08.026 (2012).
Zuniga, E., Stellabotte, F. & Crump, J. G. Jagged-Notch signaling ensures dorsal skeletal identity in the vertebrate face. Development 137, 1843–1852, doi:10.1242/dev.049056 (2010).
Barske, L. et al. Competition between Jagged-Notch and Endothelin1 Signaling Selectively Restricts Cartilage Formation in the Zebrafish Upper Face. PLoS Genet 12, e1005967, doi:10.1371/journal.pgen.1005967 (2016).
Li, L. et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 16, 243–251, doi:10.1038/ng0797-243 (1997).
Oda, T. et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 16, 235–242, doi:10.1038/ng0797-235 (1997).
Warthen, D. M. et al. Jagged1 (JAG1) mutations in Alagille syndrome: increasing the mutation detection rate. Human mutation 27, 436–443, doi:10.1002/humu.v27:5 (2006).
McDaniell, R. et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am J Hum Genet 79, 169–173, doi:10.1086/505332 (2006).
Alagille, D., Odievre, M., Gautier, M. & Dommergues, J. P. Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur. The Journal of pediatrics 86, 63–71, doi:10.1016/S0022-3476(75)80706-2 (1975).
Hartman, B. H., Reh, T. A. & Bermingham-McDonogh, O. Notch signaling specifies prosensory domains via lateral induction in the developing mammalian inner ear. Proc Natl Acad Sci USA 107, 15792–15797, doi:10.1073/pnas.1002827107 (2010).
Kiernan, A. E., Xu, J. & Gridley, T. The Notch ligand JAG1 is required for sensory progenitor development in the mammalian inner ear. PLoS Genet 2, e4, doi:10.1371/journal.pgen.0020004 (2006).
Neves, J., Parada, C., Chamizo, M. & Giraldez, F. Jagged 1 regulates the restriction of Sox2 expression in the developing chicken inner ear: a mechanism for sensory organ specification. Development 138, 735–744, doi:10.1242/dev.060657 (2011).
LaBrecque, D. R. et al. Four generations of arteriohepatic dysplasia. Hepatology 2, 467–474, doi:10.1002/hep.v2:4 (1982).
Le Caignec, C. et al. Familial deafness, congenital heart defects, and posterior embryotoxon caused by cysteine substitution in the first epidermal-growth-factor-like domain of jagged 1. Am J Hum Genet 71, 180–186, doi:10.1086/341327 (2002).
Okuno, T., Takahashi, H., Shibahara, Y., Hashida, Y. & Sando, I. Temporal bone histopathologic findings in Alagille’s syndrome. Arch Otolaryngol Head Neck Surg 116, 217–220, doi:10.1001/archotol.1990.01870020093025 (1990).
Hamada, Y. et al. Mutation in ankyrin repeats of the mouse Notch2 gene induces early embryonic lethality. Development 126, 3415–3424 (1999).
Xue, Y. et al. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Mol Genet 8, 723–730, doi:10.1093/hmg/8.5.723 (1999).
Yen, H. Y., Ting, M. C. & Maxson, R. E. Jagged1 functions downstream of Twist1 in the specification of the coronal suture and the formation of a boundary between osteogenic and non-osteogenic cells. Dev Biol 347, 258–270, doi:10.1016/j.ydbio.2010.08.010 (2010).
Hill, C. R., Yuasa, M., Schoenecker, J. & Goudy, S. L. Jagged1 is essential for osteoblast development during maxillary ossification. Bone 62, 10–21, doi:10.1016/j.bone.2014.01.019 (2014).
Humphreys, R. et al. Cranial neural crest ablation of Jagged1 recapitulates the craniofacial phenotype of Alagille syndrome patients. Hum Mol Genet 21, 1374–1383, doi:10.1093/hmg/ddr575 (2012).
Hoshino, T. Stapes anomaly and cochlear sensory cell changes. A scanning electron microscope study. Arch Otorhinolaryngol 228, 93–99, doi:10.1007/BF00455336 (1980).
Kurosaki, Y. et al. Congenital ossification of the stapedius tendon: diagnosis with CT. Radiology 195, 711–714, doi:10.1148/radiology.195.3.7753999 (1995).
Scheer, A. A. Correction of congenital middle ear deformities. Archives of otolaryngology 85, 269–277, doi:10.1001/archotol.1967.00760040271007 (1967).
Jahrsdoerfer, R. A., Aguilar, E. A., Yeakley, J. W. & Cole, R. R. Treacher Collins syndrome: an otologic challenge. The Annals of otology, rhinology, and laryngology 98, 807–812, doi:10.1177/000348948909801011 (1989).
Twigg, S. R. & Wilkie, A. O. New insights into craniofacial malformations. Hum Mol Genet 24, R50–59, doi:10.1093/hmg/ddv228 (2015).
Lamonica, D. A. et al. Saethre-Chotzen syndrome, Pro136His TWIST mutation, hearing loss, and external and middle ear structural anomalies: report on a Brazilian family. Cleft Palate Craniofac J 47, 548–552, doi:10.1597/08-251.1 (2010).
Rosen, H. et al. Audiologic findings in Saethre-Chotzen syndrome. Plast Reconstr Surg 127, 2014–2020, doi:10.1097/PRS.0b013e31820cf16a (2011).
Bialek, P. et al. A twist code determines the onset of osteoblast differentiation. Developmental cell 6, 423–435, doi:10.1016/S1534-5807(04)00058-9 (2004).
Zanotti, S. & Canalis, E. Notch Signaling and the Skeleton. Endocrine reviews 37, 223–253, doi:10.1210/er.2016-1002 (2016).
Merrill, A. E. et al. Cell mixing at a neural crest-mesoderm boundary and deficient ephrin-Eph signaling in the pathogenesis of craniosynostosis. Hum Mol Genet 15, 1319–1328, doi:10.1093/hmg/ddl052 (2006).
Teunissen, E. B. & Cremers, W. R. Classification of congenital middle ear anomalies. Report on 144 ears. The Annals of otology, rhinology, and laryngology 102, 606–612, doi:10.1177/000348949310200807 (1993).
Baba, S., Ikezono, T., Pawankar, R. & Yagi, T. Congenital malformations of the middle ear with an intact external ear: a review of 38 cases. ORL; journal for oto-rhino-laryngology and its related specialties 66, 74–79, doi:10.1159/000077799 (2004).
Tsai, H. et al. The mouse slalom mutant demonstrates a role for Jagged1 in neuroepithelial patterning in the organ of Corti. Hum Mol Genet 10, 507–512, doi:10.1093/hmg/10.5.507 (2001).
Vrijens, K. et al. Ozzy, a Jag1 vestibular mouse mutant, displays characteristics of Alagille syndrome. Neurobiol Dis 24, 28–40, doi:10.1016/j.nbd.2006.04.016 (2006).
Krantz, I. D., Piccoli, D. A. & Spinner, N. B. Alagille syndrome. Journal of medical genetics 34, 152–157, doi:10.1136/jmg.34.2.152 (1997).
Lagleyre, S. et al. Reliability of high-resolution CT scan in diagnosis of otosclerosis. Otology & neurotology: official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 30, 1152–1159, doi:10.1097/MAO.0b013e3181c2a084 (2009).
Koch, B., Goold, A., Egelhoff, J. & Benton, C. Partial absence of the posterior semicircular canal in Alagille syndrome: CT findings. Pediatr Radiol 36, 977–979, doi:10.1007/s00247-006-0230-2 (2006).
Anderson, H. & Barr, B. Conductive high-tone hearing loss. Arch Otolaryngol 93, 599–605, doi:10.1001/archotol.1971.00770060901010 (1971).
Benedito, R. et al. The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 137, 1124–1135, doi:10.1016/j.cell.2009.03.025 (2009).
Benjamin, L. E., Hemo, I. & Keshet, E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125, 1591–1598 (1998).
Mead, T. J. & Yutzey, K. E. Notch pathway regulation of neural crest cell development in vivo. Developmental dynamics: an official publication of the American Association of Anatomists 241, 376–389, doi:10.1002/dvdy.23717 (2012).
Mitsiadis, T. A., Henrique, D., Thesleff, I. & Lendahl, U. Mouse Serrate-1 (Jagged-1): expression in the developing tooth is regulated by epithelial-mesenchymal interactions and fibroblast growth factor-4. Development 124, 1473–1483 (1997).
Jiang, R. et al. Defects in limb, craniofacial, and thymic development in Jagged2 mutant mice. Genes Dev 12, 1046–1057, doi:10.1101/gad.12.7.1046 (1998).
McCright, B., Lozier, J. & Gridley, T. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 129, 1075–1082 (2002).
Kemaloglu, Y. K., Kobayashi, T. & Nakajima, T. Associations between the eustachian tube and craniofacial skeleton. International journal of pediatric otorhinolaryngology 53, 195–205, doi:10.1016/S0165-5876(00)82007-8 (2000).
Algudkar, A., Lim, B., Fan, K. & Bentley, R. Sustained bilateral middle ear effusions post orthognathic surgery successfully treated with grommet insertion. JRSM short reports 4, 2042533313489822 (2013).
Freyer, L., Aggarwal, V. & Morrow, B. E. Dual embryonic origin of the mammalian otic vesicle forming the inner ear. Development 138, 5403–5414, doi:10.1242/dev.069849 (2011).
Kiernan, A. E. et al. The Notch ligand Jagged1 is required for inner ear sensory development. Proceedings of the National Academy of Sciences of the United States of America 98, 3873–3878, doi:10.1073/pnas.071496998 (2001).
Ma, W. R. & Zhang, J. Jag1b is essential for patterning inner ear sensory cristae by regulating anterior morphogenetic tissue separation and preventing posterior cell death. Development 142, 763–773, doi:10.1242/dev.113662 (2015).
Obholzer, N. et al. Rapid positional cloning of zebrafish mutations by linkage and homozygosity mapping using whole-genome sequencing. Development 139, 4280–4290, doi:10.1242/dev.083931 (2012).
Bi, W. L. et al. Superior semicircular canal dehiscence syndrome. Journal of neurosurgery, 1–9 (2017).
Lippy, W. H., Battista, R. A., Berenholz, L., Schuring, A. G. & Burkey, J. M. Twenty-year review of revision stapedectomy. Otol Neurotol 24, 560–566, doi:10.1097/00129492-200307000-00005 (2003).
Gong, Y. et al. Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nature genetics 21, 302–304, doi:10.1038/6821 (1999).
Kornak, U. et al. Three novel mutations in the ANK membrane protein cause craniometaphyseal dysplasia with variable conductive hearing loss. American journal of medical genetics. Part A 152A, 870–874, doi:10.1002/ajmg.a.v152a:4 (2010).
Arnold, J. S. et al. Tissue-specific roles of Tbx1 in the development of the outer, middle and inner ear, defective in 22q11DS patients. Human molecular genetics 15, 1629–1639, doi:10.1093/hmg/ddl084 (2006).
Guegan, K., Stals, K., Day, M., Turnpenny, P. & Ellard, S. JAG1 mutations are found in approximately one third of patients presenting with only one or two clinical features of Alagille syndrome. Clin Genet 82, 33–40, doi:10.1111/j.1399-0004.2011.01749.x (2012).
Chen, Z. F. & Behringer, R. R. twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes & development 9, 686–699 (1995).
Brooker, R., Hozumi, K. & Lewis, J. Notch ligands with contrasting functions: Jagged1 and Delta1 in the mouse inner ear. Development 133, 1277–1286, doi:10.1242/dev.02284 (2006).
McCright, B., Lozier, J. & Gridley, T. Generation of new Notch2 mutant alleles. Genesis 44, 29–33, doi:10.1002/gene.v44:1 (2006).
Danielian, P. S., Muccino, D., Rowitch, D. H., Michael, S. K. & McMahon, A. P. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Current biology: CB 8, 1323–1326, doi:10.1016/S0960-9822(07)00562-3 (1998).
Boddupally, K., Wang, G., Chen, Y. & Kobielak, A. Lgr5 Marks Neural Crest Derived Multipotent Oral Stromal Stem Cells. Stem cells 34, 720–731, doi:10.1002/stem.2314 (2016).
Kroes, T., Post, F. H. & Botha, C. P. Exposure render: an interactive photo-realistic volume rendering framework. PloS one 7, e38586, doi:10.1371/journal.pone.0038586 (2012).
Morriss-Kay, G. M. Treatment of mice with retinoids in vivo and in vitro. Skeletal staining. Methods in molecular biology 97, 33–39, doi:10.1385/1592592708 (1999).
Acknowledgements
We would like to thank Seth Ruffins, Director of the Microscopy Core Facility of USC Stem Cell, for assistance in rendering micro-CT reconstructions. This work was supported by the National Institutes of Health [DE018405 to J.G.C, DE024031 to C.T., DE016320 to R.E.M., DC009975 to L.B.]; March of Dimes [J.G.C.]; the A. P. Giannini Foundation [L.B.]; and an NIH T32 training fellowship in hearing and communication neuroscience [DC009975 to L.B.].
Author information
Authors and Affiliations
Contributions
C.S.T. and J.G.C. conceived the experiments, C.S.T. and H.-Y.Y. performed the analysis of mouse middle ear bones, B.S. and P.A.S.-L. performed hearing tests on AGS patients, J.L. performed hearing tests on mice, J.G. examined micro-CT scans of subjects, and C.S.T., L.B., N.S., J.G., P.A.S., R.E.M., and J.G.C. analysed the results. All authors reviewed the manuscript.
Corresponding authors
Ethics declarations
Competing Interests
The authors declare that they have no competing interests.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Teng, C.S., Yen, HY., Barske, L. et al. Requirement for Jagged1-Notch2 signaling in patterning the bones of the mouse and human middle ear. Sci Rep 7, 2497 (2017). https://doi.org/10.1038/s41598-017-02574-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-017-02574-7
- Springer Nature Limited
This article is cited by
-
Alagille Syndrome: A Case Report
Indian Journal of Otolaryngology and Head & Neck Surgery (2022)